Lumican Is Both a Novel Risk Factor and Potential Plasma Biomarker for Vascular Aging, Capable of Promoting Vascular Smooth Cells Senescence Through Interacting With Integrin α2β1
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2024
DOI: 10.1093/gerona/glae214 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2024. Verfasst von Mandi Luo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Lumican, Cellular Senescence, Integrin alpha2beta1, Aging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, Major Technology Innovation of Hubei Province.
Abstract (Originalsprache)
Vascular aging, a common pathogenesis of senile chronic diseases, significantly increases morbidity and mortality in older adults; its intricate cellular and molecular mechanisms necessitate further investigation. Lumican (LUM) and integrin α2β1 are profibrotic extracellular matrix proteins and vital cell regulatory receptors, respectively. However, their roles in vascular aging remain unclear. This study sought to elucidate the connection between LUM and vascular aging as well as the biological mechanism of LUM/integrin α2β1 in this process. Using an enzyme-linked immunosorbent assay, we discovered that plasma LUM was elevated in vascular aging individuals and was positively correlated with brachial-ankle pulse wave velocity. Additionally, immunohistochemical and Western blot analyses confirmed LUM upregulation in arteries of older adults and aged mice, as well as in senescent vascular smooth cells (VSMCs). Wild-type and LUM semiknockout (Lum−/+) mice, along with primary VSMCs extracted from these mice, were exposed to angiotensin II to induce a stress-induced senescence model. LUM semiknockout mitigated angiotensin II-induced arteriosclerosis, hypertension, vascular aging, and remodeling in mice. Both in vitro and in vivo studies revealed that LUM deficiency suppressed p53, p21, collagen 1, and collagen 3 upregulation and synthetic phenotype formation in VSMCs stimulated by angiotensin II. Treating VSMCs with an integrin α2β1 antagonist reversed the aforementioned changes triggered by LUM proteins. Briefly, LUM functions as a potential marker and risk factor for vascular aging and promotes pathological changes by affecting integrin α2β1 in VSMCs. This study introduces a novel molecular target for the early diagnosis and treatment of vascular aging and age-related vascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Sciences and Technology, Huazhong University of Science and Technology, Wuhan, China.
- Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Geriatrics Medicine, Center of Coronary Circulation, Xiangya Hospital, Central South University, Changsha, China.
- BGI Genomics, Shenzhen, China.
ORCID-Profile: Shangbang Gao, Le Zhang, Yongping Bai
Förderung
- National Key R&D Program of China
- Major Technology Innovation of Hubei Province
Zitieren
APA
Luo, M., Yan, D., Huang, Y., Ji, T., Luo, P., Yang, Z., Gao, S., Zhang, L., Zhou, Y., Shi, Q., Bai, Y., Li, T., Ruan, L., & Zhang, C. (2024). Lumican Is Both a Novel Risk Factor and Potential Plasma Biomarker for Vascular Aging, Capable of Promoting Vascular Smooth Cells Senescence Through Interacting With Integrin α2β1. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glae214
Vancouver
Luo M, Yan D, Huang Y, Ji T, Luo P, Yang Z, et al. Lumican Is Both a Novel Risk Factor and Potential Plasma Biomarker for Vascular Aging, Capable of Promoting Vascular Smooth Cells Senescence Through Interacting With Integrin α2β1. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2024. doi:10.1093/gerona/glae214
BibTeX
@article{Luo2024,
author = {Luo, Mandi and Yan, Dan and Huang, Yi and Ji, Tianyi and Luo, Pengcheng and Yang, Zhen and Gao, Shangbang and Zhang, Le and Zhou, Yiwu and Shi, Qing and Bai, Yongping and Li, Tao and Ruan, Lei and Zhang, Cuntai},
title = {Lumican Is Both a Novel Risk Factor and Potential Plasma Biomarker for Vascular Aging, Capable of Promoting Vascular Smooth Cells Senescence Through Interacting With Integrin α2β1},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2024},
doi = {10.1093/gerona/glae214}
}
EUVIMED